SKDX
Desconocido
DIAMONDS: Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis
SKYLINEDX B.V.
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Our proposal will address the challenge of bringing personalised medicine into routine use in EU healthcare systems for diagnosis and treatm...
2019-12-06 - 2025-06-30 | Financiado
2019-12-06 - 2025-06-30 | Financiado
MMpredict: Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectivenes...
SKYLINEDX B.V.
participó en un
H2020:
H2020-FTIPilot-2015-1
The consortium aims to commercialise the MMpredictor as a personalised medicine tool that predicts the most effective treatment strategy for...
2016-10-30 - 2020-10-31 | Financiado
2016-10-30 - 2020-10-31 | Financiado
* No se disponen de datos de la empresa actual.